A protein fraction enriched in TGFβ2 in an activated form, said protein fraction comprising a) TGFβ2 in an activated form in a content higher than 5 micrograms per gram of total proteins of said protein fraction, b) whey proteins comprising α-lactalbumin being about 45-80% by weight of said protein fraction, and c) an immunoglobulin being about 10-25% by weight of said protein fraction, wherein said protein fraction is effective for treating psoriasis, wherein said protein fraction is obtained by the steps of:
- precipitating milk or whey by acid treatment at a pH ranging between 4 and 5.5, and at a temperature between 55° C. and 68° C. so as to obtain a precipitated suspension;
- and microfiltrating the precipitated suspension so as to obtain a microfiltration retentate containing the protein fraction enriched in TGFβ2 in an activated form.